Fact Source: Financial Supervisory Service DART
💡 3-Second Summary
Celltrion is additionally listing 25,336 common shares on May 19, 2025, following the exercise of stock options.
📊 [Key Disclosure Details & Financial Summary]
- Disclosure Title: Additional Listing (Exercise of Stock Options)
- Class and Number of Shares: 25,336 registered common shares
- Issue Price per Share by Tranche (Par Value: KRW 1,000):
- 156th Tranche: KRW 82,321 (18,158 shares)
- 157th Tranche: KRW 74,731 (2,230 shares)
- 158th Tranche: KRW 162,694 (1,783 shares)
- 159th Tranche: KRW 128,296 (2,665 shares)
- 160th Tranche: KRW 133,748 (500 shares)
- Capital Increase Method: Exercise of Stock Options
- Issue Date: April 28, 2025
- Dividend Record Date: January 1, 2025
- Listing Date: May 19, 2025
- Stock Code: Standard Code KR7068270008 (Short Code A068270)
📝 Editor’s Comment (Key Follow-up Checkpoint)
📌 Verification of Additional Listing Execution on Scheduled Date (May 19, 2025)
This disclosure details the additional listing of 25,336 common shares resulting from the exercise of stock options, making it important to confirm the completion of the listing on the scheduled date of May 19, 2025. Tracking the new share issuance ensures verification of the increase in total issued shares and capital stock. Updated total share counts and capital stock changes can be verified under ‘Total Number of Shares’ and ‘Changes in Capital Stock’ in upcoming periodic filings (Quarterly, Half-Yearly, or Annual Business Reports).
📢 Disclaimer & Source Information
Source: This content was newly generated and structured based on official data submitted to the Data Analysis, Retrieval and Transfer System (DART) of the Financial Supervisory Service.
Investment Risk Notice: This information is provided for informational and linguistic reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell any specific stock. All investment decisions and financial responsibilities rest solely with the investor.
Contact: For compliance inquiries or copyright concerns, please contact ksb220805@gmail.com.
